_id
695fb78ec2e91020a7bd4251
Ticker
0HX7.LSE
Name
Adicet Bio, Inc.
Exchange
LSE
Address
131 Dartmouth Street, Boston, MA, United States, 02116
Country
UK
Sector
Industry
Currency
USD
Website
https://www.adicetbio.com
Description
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Last Close
8.08
Volume
9
Current Price
8.07
Last Updated
2026-01-08T13:56:29.879Z
Ipo Date
-
Market Cap
42271084800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
27952000
Operating Income
-27952000
Interest Expense
12000
Pretax Income
-26856000
Net Income
-26856000
Eps
-4.717451760999308
Dividends Per Share
-
Shares Outstanding
28046800
Income Tax Expense
-
EBITDA
-25271000
Operating Margin
-
Total Other Income Expense Net
1096000
Cash
29099000
Short Term Investments
73999000
Receivables
169000
Inventories
-
Total Current Assets
106494000
Property Plant Equipment
30972000
Total Assets
140479000
Payables
4287000
Short Term Debt
3265000
Long Term Debt
-
Total Liabilities
31337000
Equity
109142000
Bs_currency_symbol
-
Depreciation
868000
Change In Working Capital
1637000
Cash From Operations
-22307000
Capital Expenditures
209000
Cash From Investing
16836000
Cash From Financing
-150000
Net Change In Cash
-5621000
Cf_currency_symbol
-
PE
-
PB
0.42093543530446575
ROE
-24.60647596708875
ROA
-19.117448159511387
FCF
-22516000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
27952000
Quarters > 0 > income Statement > operating Income
-27952000
Quarters > 0 > income Statement > interest Expense
12000
Quarters > 0 > income Statement > pretax Income
-26856000
Quarters > 0 > income Statement > net Income
-26856000
Quarters > 0 > income Statement > eps
-4.717451760999308
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
5692904
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-25271000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1096000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
29099000
Quarters > 0 > balance Sheet > short Term Investments
73999000
Quarters > 0 > balance Sheet > receivables
169000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
106494000
Quarters > 0 > balance Sheet > property Plant Equipment
30972000
Quarters > 0 > balance Sheet > total Assets
140479000
Quarters > 0 > balance Sheet > payables
4287000
Quarters > 0 > balance Sheet > short Term Debt
3265000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
31337000
Quarters > 0 > balance Sheet > equity
109142000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-26856000
Quarters > 0 > cash Flow > depreciation
868000
Quarters > 0 > cash Flow > change In Working Capital
1637000
Quarters > 0 > cash Flow > cash From Operations
-22307000
Quarters > 0 > cash Flow > capital Expenditures
209000
Quarters > 0 > cash Flow > cash From Investing
16836000
Quarters > 0 > cash Flow > cash From Financing
-150000
Quarters > 0 > cash Flow > net Change In Cash
-5621000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-4.717451760999308
Quarters > 0 > ratios > PB
0.42093543530446575
Quarters > 0 > ratios > ROE
-24.60647596708875
Quarters > 0 > ratios > ROA
-19.117448159511387
Quarters > 0 > ratios > FCF
-22516000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
1600000
Quarters > 1 > income Statement > gross Profit
-1600000
Quarters > 1 > income Statement > operating Expenses
30792000
Quarters > 1 > income Statement > operating Income
-32392000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-31217000
Quarters > 1 > income Statement > net Income
-31217000
Quarters > 1 > income Statement > eps
-5.483550928147689
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5692844
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-29617000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1175000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
34720000
Quarters > 1 > balance Sheet > short Term Investments
90243000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
127740000
Quarters > 1 > balance Sheet > property Plant Equipment
32104000
Quarters > 1 > balance Sheet > total Assets
162972000
Quarters > 1 > balance Sheet > payables
3292000
Quarters > 1 > balance Sheet > short Term Debt
2953000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
29600000
Quarters > 1 > balance Sheet > equity
133372000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-31217000
Quarters > 1 > cash Flow > depreciation
1600000
Quarters > 1 > cash Flow > change In Working Capital
58000
Quarters > 1 > cash Flow > cash From Operations
-26633000
Quarters > 1 > cash Flow > capital Expenditures
47000
Quarters > 1 > cash Flow > cash From Investing
32953000
Quarters > 1 > cash Flow > cash From Financing
267000
Quarters > 1 > cash Flow > net Change In Cash
6587000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-5.483550928147689
Quarters > 1 > ratios > PB
0.3444594898479441
Quarters > 1 > ratios > ROE
-23.405962270941426
Quarters > 1 > ratios > ROA
-19.15482414157033
Quarters > 1 > ratios > FCF
-26680000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
1680000
Quarters > 2 > income Statement > gross Profit
-1680000
Quarters > 2 > income Statement > operating Expenses
29885000
Quarters > 2 > income Statement > operating Income
-29885000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-28214000
Quarters > 2 > income Statement > net Income
-28214000
Quarters > 2 > income Statement > eps
-4.9568119269883075
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5691965
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-28205000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1671000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
28133000
Quarters > 2 > balance Sheet > short Term Investments
122306000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
153563000
Quarters > 2 > balance Sheet > property Plant Equipment
34491000
Quarters > 2 > balance Sheet > total Assets
191271000
Quarters > 2 > balance Sheet > payables
4403000
Quarters > 2 > balance Sheet > short Term Debt
2983000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
29825000
Quarters > 2 > balance Sheet > equity
161446000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-28214000
Quarters > 2 > cash Flow > depreciation
1695000
Quarters > 2 > cash Flow > change In Working Capital
-2324
Quarters > 2 > cash Flow > cash From Operations
-25397
Quarters > 2 > cash Flow > capital Expenditures
1492
Quarters > 2 > cash Flow > cash From Investing
-2861
Quarters > 2 > cash Flow > cash From Financing
-104
Quarters > 2 > cash Flow > net Change In Cash
-28362
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-4.9568119269883075
Quarters > 2 > ratios > PB
0.2845171608463511
Quarters > 2 > ratios > ROE
-17.475812345923714
Quarters > 2 > ratios > ROA
-14.750798605120483
Quarters > 2 > ratios > FCF
-26889
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
1623000
Quarters > 3 > income Statement > gross Profit
-1623000
Quarters > 3 > income Statement > operating Expenses
29120000
Quarters > 3 > income Statement > operating Income
-30743000
Quarters > 3 > income Statement > interest Expense
1000
Quarters > 3 > income Statement > pretax Income
-28727000
Quarters > 3 > income Statement > net Income
-28727000
Quarters > 3 > income Statement > eps
-5.059447228047446
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5677893
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-27103000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2016000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
56495000
Quarters > 3 > balance Sheet > short Term Investments
119808000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
180136000
Quarters > 3 > balance Sheet > property Plant Equipment
36752000
Quarters > 3 > balance Sheet > total Assets
220219000
Quarters > 3 > balance Sheet > payables
4830000
Quarters > 3 > balance Sheet > short Term Debt
3132000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
33610000
Quarters > 3 > balance Sheet > equity
186609000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-28727000
Quarters > 3 > cash Flow > depreciation
1623000
Quarters > 3 > cash Flow > change In Working Capital
-206000
Quarters > 3 > cash Flow > cash From Operations
-24101000
Quarters > 3 > cash Flow > capital Expenditures
176000
Quarters > 3 > cash Flow > cash From Investing
-22120000
Quarters > 3 > cash Flow > cash From Financing
137000
Quarters > 3 > cash Flow > net Change In Cash
-48987000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-5.059447228047446
Quarters > 3 > ratios > PB
0.2455433366557883
Quarters > 3 > ratios > ROE
-15.394220000107175
Quarters > 3 > ratios > ROA
-13.044741825183111
Quarters > 3 > ratios > FCF
-24277000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
6468000
Annuals > 0 > income Statement > gross Profit
-6468000
Annuals > 0 > income Statement > operating Expenses
121147000
Annuals > 0 > income Statement > operating Income
-127615000
Annuals > 0 > income Statement > interest Expense
4000
Annuals > 0 > income Statement > pretax Income
-117122000
Annuals > 0 > income Statement > net Income
-117122000
Annuals > 0 > income Statement > eps
-21.327280024298698
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5491652
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-110650000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
10493000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
56495000
Annuals > 0 > balance Sheet > short Term Investments
119808000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
180136000
Annuals > 0 > balance Sheet > property Plant Equipment
36752000
Annuals > 0 > balance Sheet > total Assets
220219000
Annuals > 0 > balance Sheet > payables
4830000
Annuals > 0 > balance Sheet > short Term Debt
3132000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
33610000
Annuals > 0 > balance Sheet > equity
186609000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-117122000
Annuals > 0 > cash Flow > depreciation
6468000
Annuals > 0 > cash Flow > change In Working Capital
-5525000
Annuals > 0 > cash Flow > cash From Operations
-92378000
Annuals > 0 > cash Flow > capital Expenditures
1118000
Annuals > 0 > cash Flow > cash From Investing
-119242000
Annuals > 0 > cash Flow > cash From Financing
111307000
Annuals > 0 > cash Flow > net Change In Cash
-103216000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-21.327280024298698
Annuals > 0 > ratios > PB
0.23748925100075563
Annuals > 0 > ratios > ROE
-62.76331795358209
Annuals > 0 > ratios > ROA
-53.184330144083845
Annuals > 0 > ratios > FCF
-93496000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
42
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
6098000
Annuals > 1 > income Statement > gross Profit
-6098000
Annuals > 1 > income Statement > operating Expenses
126478000
Annuals > 1 > income Statement > operating Income
-152038000
Annuals > 1 > income Statement > interest Expense
25000
Annuals > 1 > income Statement > pretax Income
-142658000
Annuals > 1 > income Statement > net Income
-142658000
Annuals > 1 > income Statement > eps
-53.029756705016446
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2690150
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-136535000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-10082000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
159711000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
162272000
Annuals > 1 > balance Sheet > property Plant Equipment
44201000
Annuals > 1 > balance Sheet > total Assets
207295000
Annuals > 1 > balance Sheet > payables
2625000
Annuals > 1 > balance Sheet > short Term Debt
6442000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
37120000
Annuals > 1 > balance Sheet > equity
170175000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-142658
Annuals > 1 > cash Flow > depreciation
6128
Annuals > 1 > cash Flow > change In Working Capital
1935
Annuals > 1 > cash Flow > cash From Operations
-93717
Annuals > 1 > cash Flow > capital Expenditures
4464
Annuals > 1 > cash Flow > cash From Investing
-4464
Annuals > 1 > cash Flow > cash From Financing
236
Annuals > 1 > cash Flow > net Change In Cash
-97945
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-53.029756705016446
Annuals > 1 > ratios > PB
0.12757167915381226
Annuals > 1 > ratios > ROE
-83.8301748200382
Annuals > 1 > ratios > ROA
-68.81883306399094
Annuals > 1 > ratios > FCF
-98181
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
42
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
24990000
Annuals > 2 > income Statement > cost Of Revenue
5009000
Annuals > 2 > income Statement > gross Profit
19981000
Annuals > 2 > income Statement > operating Expenses
92532000
Annuals > 2 > income Statement > operating Income
-72551000
Annuals > 2 > income Statement > interest Expense
80000
Annuals > 2 > income Statement > pretax Income
-69790000
Annuals > 2 > income Statement > net Income
-69790000
Annuals > 2 > income Statement > eps
-27.1818931746535
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2567518
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-64701000
Annuals > 2 > income Statement > operating Margin
-290.3201280512205
Annuals > 2 > income Statement > total Other Income Expense Net
2761000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
257656000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
435000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
261038000
Annuals > 2 > balance Sheet > property Plant Equipment
48979000
Annuals > 2 > balance Sheet > total Assets
330690000
Annuals > 2 > balance Sheet > payables
4404000
Annuals > 2 > balance Sheet > short Term Debt
4984000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
38352000
Annuals > 2 > balance Sheet > equity
292338000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-69790000
Annuals > 2 > cash Flow > depreciation
5009000
Annuals > 2 > cash Flow > change In Working Capital
2744000
Annuals > 2 > cash Flow > cash From Operations
-45129000
Annuals > 2 > cash Flow > capital Expenditures
16782000
Annuals > 2 > cash Flow > cash From Investing
-16782000
Annuals > 2 > cash Flow > cash From Financing
41873000
Annuals > 2 > cash Flow > net Change In Cash
-19888000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-27.1818931746535
Annuals > 2 > ratios > PB
0.07087641791351107
Annuals > 2 > ratios > ROE
-23.873051057337737
Annuals > 2 > ratios > ROA
-21.104357555414435
Annuals > 2 > ratios > FCF
-61911000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.4774309723889556
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
9730000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
9730000
Annuals > 3 > income Statement > operating Expenses
71163000
Annuals > 3 > income Statement > operating Income
-61433000
Annuals > 3 > income Statement > interest Expense
176000
Annuals > 3 > income Statement > pretax Income
-62124000
Annuals > 3 > income Statement > net Income
-61999000
Annuals > 3 > income Statement > eps
-32.048942626298135
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1934510
Annuals > 3 > income Statement > income Tax Expense
-125000
Annuals > 3 > income Statement > EBITDA
-57881000
Annuals > 3 > income Statement > operating Margin
-631.377183967112
Annuals > 3 > income Statement > total Other Income Expense Net
-691000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
277544000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
185000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
282438000
Annuals > 3 > balance Sheet > property Plant Equipment
35001000
Annuals > 3 > balance Sheet > total Assets
338938000
Annuals > 3 > balance Sheet > payables
3263000
Annuals > 3 > balance Sheet > short Term Debt
3134000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
35809000
Annuals > 3 > balance Sheet > equity
303129000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-61999000
Annuals > 3 > cash Flow > depreciation
4067000
Annuals > 3 > cash Flow > change In Working Capital
-6057000
Annuals > 3 > cash Flow > cash From Operations
-51313000
Annuals > 3 > cash Flow > capital Expenditures
13046000
Annuals > 3 > cash Flow > cash From Investing
-2796000
Annuals > 3 > cash Flow > cash From Financing
242946000
Annuals > 3 > cash Flow > net Change In Cash
193214000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-32.048942626298135
Annuals > 3 > ratios > PB
0.05150116188157517
Annuals > 3 > ratios > ROE
-20.45300845514616
Annuals > 3 > ratios > ROA
-18.292136024877706
Annuals > 3 > ratios > FCF
-64359000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-6.614491264131552
Annuals > 3 > health Score
33
Valuation > metrics > PE
-4.717451760999308
Valuation > metrics > PB
0.42093543530446575
Valuation > final Score
70
Valuation > verdict
57.9% Undervalued
Profitability > metrics > ROE
-24.60647596708875
Profitability > metrics > ROA
-25.218322158994873
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.28712136482747247
Risk > metrics > Interest Coverage
-2329.3333333333335
Risk > final Score
-9257
Risk > verdict
High
Liquidity > metrics > Current Ratio
14.101430084745763
Liquidity > metrics > Quick Ratio
14.101430084745763
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-21
Prev Risks > 1
-13222
Prev Risks > 2
-122912
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:32.407Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-2.86
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Adicet Bio, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-2.86
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.